Pro Medicus Full Year 2023 Earnings: Beats Expectations
Pro Medicus (ASX:PME) Full Year 2023 Results
Key Financial Results
Revenue: AU$127.3m (up 35% from FY 2022).
Net income: AU$60.6m (up 37% from FY 2022).
Profit margin: 48% (in line with FY 2022).
EPS: AU$0.58 (up from AU$0.43 in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Pro Medicus Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates by 3.3%. Earnings per share (EPS) also surpassed analyst estimates by 3.7%.
Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Healthcare Services industry in Australia.
Performance of the Australian Healthcare Services industry.
The company's shares are up 1.4% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. See our latest analysis on Pro Medicus' balance sheet health.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.